Entela Bollano
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Background Acute myocarditis (AM) is an inflammatory cardiac condition with variable prognosis, ranging from complete recovery to progressive heart failure (HF) or death. While advances in diagnostics, such as high-sensitivity troponins and cardiac magnetic resonance imaging (CMR), have facilitated detection of milder cases, prognostic insights across unselected, real-world populations remain limited. Methods In this retrospective cohort study, we analyzed 471 consecutive patients hospitalized with a discharge diagnosis of AM between 2009 and 2019. Inclusion was based on clinical diagnosis. Baseline clinical features, laboratory data, and imaging results were extracted and systematically reviewed. The primary composite outcome comprised all-cause mortality, heart transplantation, use of mechanical circulatory support, new-onset HF, ventricular arrhythmias, and cardiac device implantation. Results The median age was 34 years, 32% were female. Chest pain was the predominant presenting symptom (87%), while ST-segment elevation was observed in 48% of cases. At admission, 24.2% of patients had hypokinesia on echocardiography, and 11.6% had a left ventricular ejection fraction (LVEF) <50%. Within the first year of follow-up, 41 patients (8.7%) experienced the composite outcome. Older age, dyspnea at presentation, and elevated biomarkers were associated with adverse events in the first year. Over a median follow-up of 8.2 years, multivariable analysis revealed age (HR 1.05 per year, 95% CI: 1.03–1.07, p<0.001), signs of HF (HR 3.27, 95% CI: 1.25–8.52, p=0.015), and hypokinesia on echocardiography (HR 19.77, 95% CI: 4.10–95.36, p<0.001) as independent predictors of poor outcomes. No sex-based difference in the primary outcome was observed (HR 0.78, 95% CI: 0.31-1.96, p=0.592) despite different clinical presentation. Conclusions In this real-world, decade-long cohort, the majority of patients had favorable outcomes. However, a small subset experienced poor outcomes in both the short and long term, highlighting the need for early risk stratification and targeted management of high-risk individuals. What is new? This is one of the largest real-world cohorts (n = 471) of patients hospitalized with acute myocarditis (AM) diagnosed through clinical judgment, CMR, or EMB over a 10-year period. Unlike prior studies, inclusion was not limited to CMR-or biopsy-confirmed cases, offering a more representative clinical picture. Most patients (87.9%) had favorable long-term outcomes; early adverse events were significantly associated with: older age; heart failure signs at admission and regional hypokinesia. What are the clinical implications? Bedside clinical features, particularly heart failure symptoms and echocardiographic hypokinesia are powerful early predictors of poor prognosis and can guide triage and monitoring decisions. Patients without chest pain, or presenting with dyspnea, elevated NT-proBNP, and regional wall motion abnormalities, are at higher risk and may require closer follow-up. This study offers a more inclusive and practical understanding of AM prognosis and supports risk-adapted strategies in real-world cardiology.
Year:
2025
The hemodynamic definitions of pulmonary hypertension consider resistive loading (pulmonary vascular resistance [PVR]), but there are increasing evidence that pulsatile loading (pulmonary artery compliance [PAC]) has functional and prognostic importance. The aims of the present study on patients with left heart disease, were to evaluate a novel echocardiographic right ventricular (RV) afterload score and to investigate its relation to risk of mortality or implantation of a left ventricular assist device. Patients ( n = 220) with left ventricular ejection fraction 3 Wood units (WU). One point was allocated for sPAP Doppler 36–59 mmHg and for pressure reflection variables above the upper normal limit. Low afterload was defined as 0‐to‐1 points, intermediate as 2‐to‐4 points, and high as 5‐to‐8 points. There were in‐between the groups significant differences in PAC and PVR. A 5‐point RV dysfunction score showed with stepwise increased RV afterload more severe dysfunction. Unadjusted hazard ratio for endpoint was 3.34 (1.69–6.79) for intermediate score, and 5.11 (2.52–10.40) for patients with high score. In conclusion, in patients with severe heart failure, a novel echocardiographic RV afterload score is related to increased pulsatile and resistant load, more severe RV dysfunction, and increased risk of adverse outcome.
Year:
2024
Background Acute myocarditis/perimyocarditis presents with a variable prognosis ranging from complete recovery to end‐stage heart failure (HF), sudden cardiac arrest, and death. The relationship between a prior history of myocarditis/perimyocarditis and outcomes in out‐of‐hospital cardiac arrest remains unclear. Methods and Results Using the SCRR (Swedish Cardiopulmonary Resuscitation Registry), we analyzed 54 568 cases of out‐of‐hospital cardiac arrest from 2010 to 2020 where cardiopulmonary resuscitation was attempted. Patients with a history of myocarditis/perimyocarditis were compared with those without in terms of characteristics and survival. Four hundred ninety‐eight patients (0.9%) had a history of myocarditis/perimyocarditis. These patients were predominantly men (73.8%), had an average age of 68 years, displayed a higher prevalence of cardiovascular comorbidities, and more frequently displayed shockable initial rhythms (28.7% versus 23.1%). Prior myocarditis/pericarditis did not correlate with worse short‐term (odds ratio [OR], 0.91 [95% CI, 0.61–1.33]) or long‐term survival (hazard ratio [HR], 1.01 [95% CI, 0.91–1.13]). Patients with myocarditis/perimyocarditis with concomitant HF showed worse long‐term survival in unadjusted analyses. Adjusted analyses confirmed that absence of HF was linked to improved short‐term survival (OR, 1.46 [95% CI, 1.32–1.62]), whereas prevalence of HF was a predictor for worsened long‐term survival (HR, 0.91 [95% CI, 0.91–0.95]) after out‐of‐hospital cardiac arrest. Analyses were adjusted for myocarditis/perimyocarditis, sex, age, HF, time to cardiopulmonary resuscitation start, and initial rhythm. Conclusions Prior myocarditis/perimyocarditis per se did not contribute to a worsened outcome following out‐of‐hospital cardiac arrest. However, the presence of concomitant HF was linked to unfavorable short‐ and long‐term outcomes.
Year:
2024
Background Cardiac involvement can be an initial manifestation in sarcoidosis. However, little is known about the association between various clinical phenotypes of cardiac sarcoidosis (CS) and outcomes. We aimed to analyze the relation of different clinical manifestations with outcomes of CS and to investigate the relative importance of clinical features influencing overall survival. Methods and Results A retrospective cohort of 141 patients with CS enrolled at 2 Swedish university hospitals was studied. Presentation, imaging studies, and outcomes of de novo CS and previously known extracardiac sarcoidosis were compared. Survival free of primary composite outcome (ventricular arrhythmias, heart transplantation, or death) was assessed. Machine learning algorithm was used to study the relative importance of clinical features in predicting outcome. Sixty‐two patients with de novo CS and 79 with previously known extracardiac sarcoidosis were included. De novo CS showed more advanced New York Heart Association class ( P =0.02), higher circulating levels of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) ( P <0.001), and troponins ( P <0.001), as well as a higher prevalence of right ventricular dysfunction ( P <0.001). During a median (interquartile range) follow‐up of 61 (44–77) months, event‐free survival was shorter in patients with de novo CS ( P <0.001). The top 5 features predicting worse event‐free survival in order of importance were as follows: impaired tricuspid annular plane systolic excursion, de novo CS, reduced right ventricular ejection fraction, absence of β‐blockers, and lower left ventricular ejection fraction. Conclusions Patients with de novo CS displayed more severe disease and worse outcomes compared with patients with previously known extracardiac sarcoidosis. Using machine learning, right ventricular dysfunction and de novo CS stand out as strong overall predictors of impaired survival.
Year:
2023
Collaborators (5)
Emanuele Bobbio
Sahlgrenska universitetssjukhuset
Sven‐Erik Ricksten
-
Thomas Lindow
Lund University
Clara Hjalmarsson
MD PhD
Sahlgrenska universitetssjukhuset
Christian Lars Polte
Karolinska University Hospital
Make your next move.
Prepare your application
Review drafts before you send them.